Also, the Pavlakis group (31) showed that multiple peri-tumoral injections of hetIL-15, the heterodimeric IL-15/IL-15Rα (7, 10) in EO771 TNBC tumors resulted in significant tumor regression, increased host survival and prevention or elimination of metastasis. The gene discussed is IL15; the disease is neoplasm.